<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Connect</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Connect</journal-id>
<journal-id journal-id-type="publisher-id">brain</journal-id>
<journal-title-group>
<journal-title>Brain Connectivity</journal-title>
</journal-title-group>
<issn pub-type="ppub">2158-0014</issn>
<issn pub-type="epub">2158-0022</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc., publishers</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30588822</article-id>
<article-id pub-id-type="pmc">6479236</article-id>
<article-id pub-id-type="publisher-id">10.1089/brain.2018.0639</article-id>
<article-id pub-id-type="doi">10.1089/brain.2018.0639</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Parvalbumin Cell Ablation of NMDA-R1 Leads to Altered Phase, But Not Amplitude, of Gamma-Band Cross-Frequency Coupling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Port</surname>
<given-names>Russell G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berman</surname>
<given-names>Jeffrey I.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Featherstone</surname>
<given-names>Robert E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>Timothy P.L.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Siegel</surname>
<given-names>Steven J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="corr1"></xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</aff>
<aff id="aff2"><label><sup>2</sup></label>Lurie Family Foundations MEG Imaging Center, Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</aff>
<aff id="aff3"><label><sup>3</sup></label>Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.</aff>
</contrib-group>
<author-notes>
<corresp id="corr1">Address correspondence to: Steven J. Siegel, Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, 2250 Alcazar Street, Suite 2200, Los Angeles, CA 90033 <email>steven.siegel@med.usc.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>4</month>
<year>2019</year>
<!--string-date: April 2019-->
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>9</volume>
<issue>3</issue>
<fpage>263</fpage>
<lpage>272</lpage>
<permissions>
<copyright-statement>Copyright 2019, Mary Ann Liebert, Inc., publishers</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="brain.2018.0639.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>Altered gamma-band electrophysiological activity in individuals with autism spectrum disorder (ASD) is well documented, and analogous gamma-band alterations are recapitulated in several preclinical murine models relevant to ASD. Such gamma-band activity is hypothesized to underlie local circuit processes. Gamma-band cross-frequency coupling (CFC), a related though distinct metric, interrogates local neural circuit signal integration. Several recent studies have observed perturbed gamma-band CFC in individuals with ASD, although the direction of change remains unresolved. It also remains unclear whether murine models relevant to ASD recapitulate this altered gamma-band CFC. As such, this study examined whether mice with parvalbumin (PV) cell-specific ablation of NMDA-R1 (PV<sub>cre</sub>/NR1<sub>fl/fl</sub>) demonstrated altered gamma-band CFC as compared with their control littermates (PV<sub>cre</sub>/NR1<sub>+/+</sub>—mice that do not have the PV cell-specific ablation of NMDA-R1). Ten mice of each genotype had 4 min of “resting” electroencephalography recorded and analyzed. First, resting electrophysiological power was parsed into the canonical frequency bands and genotype-related differences were subsequently explored so as to provide context for the subsequent CFC analyses. PV<sub>cre</sub>/NR1<sub>fl/fl</sub> mice exhibited an increase in resting power specific to the high gamma-band, but not other frequency bands, as compared with PV<sub>cre</sub>/NR1<sub>+/+</sub>. CFC analyses then examined both the standard magnitude (strength) of CFC and the novel metric Phase<sub>Max</sub>—which denotes the phase of the lower frequency signal at which the peak higher frequency signal power occurred. PV<sub>cre</sub>/NR1<sub>fl/fl</sub> mice exhibited altered Phase<sub>Max</sub>, but not strength, of gamma-band CFC as compared with PV<sub>cre</sub>/NR1<sub>+/+</sub> mice. As such, this study suggests a potential novel metric to explore when studying neuropsychiatric disorders.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>ASD</kwd>
<kwd>cross-frequency coupling</kwd>
<kwd>gamma</kwd>
<kwd>phase</kwd>
<kwd>phase-amplitude coupling</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<ref-count count="64"></ref-count>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>